by Olivia Pollock | Jun 11, 2025 | Oxbryta, Douglass Kreis
Sickle cell disease (SCD) is a complex, inherited blood disorder that affects millions of people worldwide, with a particularly high prevalence among individuals of African, Middle Eastern, Mediterranean, and South Asian descent. Despite its global impact, sickle cell...
by awkolaw2 | Oct 22, 2024 | Oxbryta
SAN FRANCISCO, CALIF., October 22, 2024 – Trebor Hardiman, a sickle cell patient from California, has filed a lawsuit against Pfizer’s wholly owned subsidiary Global Blood Therapeutics, Inc., claiming that the medication Oxbryta, developed, distributed, and sold by...
